Phibro Animal Health (NASDAQ:PAHC) Issues FY 2025 Earnings Guidance

Phibro Animal Health (NASDAQ:PAHC) updated its FY 2025 earnings guidance on Wednesday. The company provided earnings per share guidance of 1.870-2.010 for the period, compared to the consensus earnings per share estimate of 1.710. The company issued revenue guidance of $1.3 billion-$1.3 billion, compared to the consensus revenue estimate of $1.3 billion.

Analyst Upgrades and Downgrades

Several research firms have commented on PAHC. StockNews.com raised shares of Phibro Animal Health from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, January 29th. Barclays boosted their target price on Phibro Animal Health from $13.00 to $20.00 and gave the stock an “underweight” rating in a report on Tuesday, November 12th. Finally, Morgan Stanley increased their price target on Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a research note on Tuesday, December 17th. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $20.50.

Phibro Animal Health Stock Up 1.6 %

Shares of PAHC traded up $0.35 during mid-day trading on Wednesday, reaching $22.37. The company’s stock had a trading volume of 149,110 shares, compared to its average volume of 141,187. The company has a market cap of $905.99 million, a price-to-earnings ratio of 52.02, a price-to-earnings-growth ratio of 0.56 and a beta of 0.52. The business has a fifty day moving average of $21.89 and a 200 day moving average of $21.60. The company has a quick ratio of 1.69, a current ratio of 3.23 and a debt-to-equity ratio of 1.81. Phibro Animal Health has a 1 year low of $10.03 and a 1 year high of $25.98.

Phibro Animal Health (NASDAQ:PAHC) last announced its quarterly earnings data on Wednesday, February 5th. The company reported $0.54 EPS for the quarter, topping analysts’ consensus estimates of $0.40 by $0.14. Phibro Animal Health had a return on equity of 21.59% and a net margin of 1.67%. As a group, analysts forecast that Phibro Animal Health will post 1.62 earnings per share for the current fiscal year.

Phibro Animal Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Wednesday, March 5th will be paid a $0.12 dividend. The ex-dividend date of this dividend is Wednesday, March 5th. This represents a $0.48 dividend on an annualized basis and a yield of 2.15%. Phibro Animal Health’s dividend payout ratio (DPR) is currently 111.63%.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.